期刊文献+

新疆喀什地区2010—2017年新生儿疾病筛查结果分析 被引量:1

Analysis of screening results of neonatal diseases in Kashi region of Xinjiang in 2010-2017
原文传递
导出
摘要 目的分析新疆喀什地区2010-2017年新生儿疾病的筛查结果。方法采集新生儿足跟血,进行先天性甲状腺功能减退症(CH)及苯丙酮尿症(PKU)筛查。结果 2010-2017年,新疆喀什地区共筛查新生儿293 925名,筛查率由2010年的0.21%提高到2017年99.34%,共确诊CH34例,平均检出率1:8645;PKU51例,平均检出率1:5763。93.75%的接受治疗的CH患儿及84.44%的接受治疗的PKU患儿经持续治疗后智能和体格发育正常。结论新生儿疾病筛查是减少出生缺陷的重要手段,通过筛查和早期治疗,可使患儿智力达到正常水平,减少弱智儿童的发病率;有效开展新生儿疾病筛查,对提高人口素质起着积极的推动作用. Objective:To analyze the screening results of neonatal diseases in Kashi region of Xinjiang from 2010 to 2017.Methods:Neonatal heel blood of neonate was collected for congenital hypothyroidism(CH)and phenylketonuria(PKU)screening. Results:From 2010 to 2017,a total of 293 925 newborns were screened in Kashi region of Xinjiang,and the screening rate increased from 0.21% in 2010 to 99.33% in 2017. A total of 34 cases were diagnosed as CH,and the average detection rate was1:8645. 51 cases were diagnosed as PKU,and the average detection rate was 1:5763. After continuous treatment,93.75% of treated CH children patients and 84.44% treated PKU children patients would have normal intelligence and physical development.Conclusion:Neonatal disease screening is an important means to reduce birth defects. Through screening and early treatment,it can make children′ s intelligence reach normal level and reduce the incidence rate of mentally handicapped children. Effective screening of neonatal diseases will be carried out to positively promote the quality of the population.
作者 杨蛟 苏雅洁 刘永巧 李龙 YANG Jiao;SU Yajie;LIU Yong-qiao;LI Long(Department of Neonatology, People's Hospital of Xinjiang Uygur Autonomous Region,Xinjiang Urumqi 830000)
出处 《中国优生与遗传杂志》 2019年第6期728-730,共3页 Chinese Journal of Birth Health & Heredity
基金 新疆维吾尔自治区自然科学基金资助项目(编号:2016D01C116)
关键词 新生儿筛查 随访 先天性甲状腺功能减低症 苯丙酮尿症 Neonatal screening Follow-up Congenital hypothyroidism Phenylketonuria
  • 相关文献

参考文献3

二级参考文献34

  • 1张誌,何蕴韶.苯丙酮尿症分子遗传学研究进展[J].遗传,2004,26(5):729-734. 被引量:21
  • 2张军力,孟峻,翟晓萍,方根,高建钢,史珉,王永祥.经典型苯丙酮尿症苯丙氨酸羟化酶基因的新突变鉴定[J].中华医学遗传学杂志,2005,22(2):134-137. 被引量:16
  • 3宋昉,瞿宇晋,杨艳玲,金煜炜,张玉敏,王红,余伍忠.中国北方地区苯丙氨酸羟化酶基因的突变构成[J].中华医学遗传学杂志,2007,24(3):241-246. 被引量:58
  • 4Woo SL, Lidsky AS, Guttler F, et al. Clone human phenylalanine hydroxylase gene allows prenatal diagnosis and carrier detection of classical phylketonuria[J]. Nature, 1983, 306(5939): 151-155.
  • 5Guldberg P, Romano V, Cerattp NP, et al. Mutational spectrum ofphenylalanine hydroxylase defiency in Sicily: implications for diagnosis of hyper pheenylalaninemaia in Southern Europe[J]. Hum Mol Genet, 1993, 2(10): 1703-1707.
  • 6Chien YH, Chiang SC, Huang A, et al. Mutation apectrum in Taiwan Residents patients with phenylalanine hydroxylase deficiency and a founder effect for the R241C mutation[J]. Hum Murat, 2004, 23(2): 206.
  • 7Shen DY, Wu W, Zhao ZY. Mutations in patients withhyperphenylalaninemia in zhejiang, China[J]. Genes Genom, 2009, 31(1): 85-88.
  • 8Okano Y, Asada M, Kang Y, et al. Molecular characterization of phenylketonuria in Japanese patients[J]. Hum Genet, 1998, 103(5): 613-618.
  • 9Johamnes Z. Phenylketonuria mutations in Europe[J]. Hum Murat, 2003, 21(4): 345-356.
  • 10Yu WZ, Qiu DH, Song F, et al. Mutation characteristics of the PAH gene in four Nationality groups in Xinjiang of China[J]. J Genet, 2008, 87(3): 293-297.

共引文献22

同被引文献11

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部